[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders]
- PMID: 12692986
[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders]
Abstract
Objective: To elucidate the clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in connective tissue disorders.
Methods: 139 patients with various connective tissue disorders were subjected for the study, which included 46 cases of rheumatoid arthritis, 43 cases of Sjögren's syndrome, 16 cases of SLE, 10 cases of systemic sclerosis, 9 cases of polymyositis/dermatomyositis, 6 cases of vasculitis syndrome, 5 cases of Behçet's disease and 4 cases of MCTD. Serum levels of KL-6 and SP-D were determined by enzyme-immunoassay. The sensitivity, specificity and accuracy of serum KL-6 and SP-D for the diagnosis of interstitial lung disease were compared with serum LDH. The relationship of serum KL-6 and SP-D levels with high resolution CT (HRCT) of the lung and Gallium scintigraphy findings was analyzed. In some cases, serum levels of the two markers were determined monthly in the course of the disease.
Results: When the serum levels of KL-6 and SP-D were measured simultaneously, the sensitivity to diagnose interstitial lung disease was 67.7%, the specificity was 98.1%, and the accuracy was 91.4%, while those of serum LDH were 45.2%, 88.9%, 79.1% respectively. In the patients with interstitial lung disease, those who had elevated serum levels of both KL-6 and SP-D showed parenchymal collapse opacity-dominant pattern in HRCT. On the other hand, the patients with interstitial lung disease who had normal levels of serum KL-6 and SP-D or had elevation either in KL-6 or SP-D levels showed ground glass opacity-dominant pattern in HRCT. There was no significant correlation between serum marker levels and Gallium scintigraphy findings. When serum KL-6 and SP-D were measured monthly, the levels of both markers changed more specifically and sensitively to the lung disease activity compared with serum LDH.
Conclusions: Serum KL-6 and SP-D are more specific and useful markers for the diagnosis and evaluation of interstitial lung disease compared with serum LDH in connective tissue disorders.
Similar articles
-
[Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].Ryumachi. 2003 Feb;43(1):11-8. Ryumachi. 2003. PMID: 12692985 Japanese.
-
[The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].Rinsho Byori. 2000 Jun;48(6):554-60. Rinsho Byori. 2000. PMID: 10897675 Clinical Trial. Japanese.
-
A case of Wilson-Mikity syndrome with high serum KL-6 levels.J Perinatol. 2003 Jan;23(1):56-8. doi: 10.1038/sj.jp.7210830. J Perinatol. 2003. PMID: 12556928
-
[Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:186-9. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 9216213 Review. Japanese.
-
Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.J Med Invest. 1999 Aug;46(3-4):151-8. J Med Invest. 1999. PMID: 10687309 Review.
Cited by
-
Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?Arch Rheumatol. 2018 Jan 29;33(4):431-437. doi: 10.5606/ArchRheumatol.2018.6691. eCollection 2018 Dec. Arch Rheumatol. 2018. PMID: 30874239 Free PMC article.
-
CA 15 - 3 in screening for systemic autoimmune rheumatic disease associated interstitial lung disease: a single center cross-sectional study.Rheumatol Int. 2024 Oct;44(10):2017-2025. doi: 10.1007/s00296-024-05694-2. Epub 2024 Aug 24. Rheumatol Int. 2024. PMID: 39180532
-
Diagnostic Value of Serum KL-6 in Interstitial Lung Diseases.Int J Gen Med. 2024 Aug 23;17:3649-3661. doi: 10.2147/IJGM.S435754. eCollection 2024. Int J Gen Med. 2024. PMID: 39193261 Free PMC article.
-
The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.BMC Pulm Med. 2020 Jan 8;20(1):6. doi: 10.1186/s12890-019-1043-z. BMC Pulm Med. 2020. PMID: 31915006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous